e.g. Tata motors, Reliance MF, 500570

Beta Drugs Ltd. - Research Center

Group () BSE data
 
Back to Company Page
Results:

Annual results in brief

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Sales 220.20 197.62 157.87 124.85 79.46
Operating profit 31.42 33.53 31.20 25.18 15.31
Interest 4.76 1.05 0.84 0.41 0.77
Gross profit 32.85 34.21 31.40 25.63 15.15
EPS (Rs) 15.29 22.82 19.57 14.82 7.26

Annual  results in details

Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Other income 6.19 1.73 1.04 0.86 0.61
Stock adjustment -3.70 -6.97 -3.17 0.86 -1.38
Raw material 123.50 119.27 86.47 69.86 44.83
Power and fuel - - - - -
Employee expenses 18.95 14.32 13.42 8.72 6.06
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 50.04 37.48 29.96 20.21 14.64
Provisions made - - - - -
Depreciation 7.44 4.72 6.19 5.47 5.27
Taxation 5.41 7.55 6.39 5.92 2.90
Net profit / loss 15.43 21.94 18.82 14.25 6.98
Extra ordinary item -4.57 - - - -
Prior year adjustments - - - - -
Equity capital 10.09 9.61 9.61 9.61 9.61
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 14.27 16.96 19.76 20.17 19.27
GPM (%) 14.51 17.16 19.76 20.39 18.92
NPM (%) 6.82 11.00 11.84 11.33 8.71
Close
Add Beta Drugs Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Beta Drugs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback